Study Evaluating GAP-486 in Heart Rhythm

• Status: Terminated
• Trial end date: 2006-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to learn the effects of a test drug on heart rhythm, and to provide additional data to see if the test drug is well tolerated and safe.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Criteria

Inclusion Criteria:

• Patients undergoing an electrophysiology study for evaluation of heart rhythm.

Exclusion Criteria:

• Patients with uncontrolled blood pressure

• Patients with certain cardiac risk factors

• Patients with significant kidney or liver problems